These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10540198)

  • 21. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes.
    van Bavel CC; Dieker JW; Tamboer WP; van der Vlag J; Berden JH
    Mol Immunol; 2010; 48(1-3):248-56. PubMed ID: 20817300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to new cytoplasmic autoantigens: anti-JA, a potential marker for disease activity in systemic lupus erythematosus.
    Bonfa E; Tavares AV; Viana VS; Levy-Neto M; Kumeda CA; Cossermelli W
    Braz J Med Biol Res; 1992; 25(6):601-9. PubMed ID: 1342236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FSAP-mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE.
    Marsman G; Stephan F; de Leeuw K; Bulder I; Ruinard JT; de Jong J; Westra J; Bultink IE; Voskuyl AE; Aarden LA; Luken BM; Kallenberg CG; Zeerleder S
    Eur J Immunol; 2016 Mar; 46(3):762-71. PubMed ID: 26626052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineutrophil cytoplasmic autoantibodies in patients with systemic lupus erythematosus recognize a novel 69 kDa target antigen of neutrophil granules.
    Chen M; Zhao MH; Zhang YK; Wang HY
    Nephrology (Carlton); 2005 Oct; 10(5):491-5. PubMed ID: 16221101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus.
    Utz PJ; Hottelet M; Schur PH; Anderson P
    J Exp Med; 1997 Mar; 185(5):843-54. PubMed ID: 9120390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of a calreticulin-binding nuclear protein as histone (H1), an autoantigen in systemic lupus erythematosus.
    Treves S; Bajocchi G; Zorzato F; Govoni M; Trotta F
    Lupus; 1998; 7(7):479-87. PubMed ID: 9796851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial cell binding by systemic lupus antibodies: functional properties and relationship with anti-DNA activity.
    Moscato S; Pratesi F; Bongiorni F; Scavuzzo MC; Chimenti D; Bombardieri S; Migliorini P
    J Autoimmun; 2002 May; 18(3):231-8. PubMed ID: 12126636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: liver-kidney microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue.
    Kyriatsoulis A; Manns M; Gerken G; Lohse AW; Ballhausen W; Reske K; Meyer zum Büschenfelde KH
    Clin Exp Immunol; 1987 Oct; 70(1):53-60. PubMed ID: 3690894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of novel antigens recognized by serum autoantibodies from anti-CD1 TCR-transgenic lupus mice.
    Hueber W; Zeng D; Sharpe O; Robinson WH; Strober S; Utz PJ
    Eur J Immunol; 2004 Jun; 34(6):1654-62. PubMed ID: 15162435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis.
    Abeler-Dörner L; Rieger CC; Berger B; Weyd H; Gräf D; Pfrang S; Tarner IH; Schwarting A; Lorenz HM; Müller-Ladner U; Krammer PH; Kuhn A
    J Rheumatol; 2013 Oct; 40(10):1683-96. PubMed ID: 24037549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing.
    Costa S; Borgogna C; Mondini M; De Andrea M; Meroni PL; Berti E; Gariglio M; Landolfo S
    Br J Dermatol; 2011 Feb; 164(2):282-90. PubMed ID: 20973769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.
    Quan J; Lakhanpal A; Reddy MM; Zaman S; Li QZ; German DC; Olsen NJ; Kodadek T; Karp DR
    J Immunol Methods; 2014 Jan; 402(1-2):23-34. PubMed ID: 24269750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
    Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
    Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes.
    Kishore U; Sontheimer RD; Sastry KN; Zappi EG; Hughes GR; Khamashta MA; Reid KB; Eggleton P
    Clin Exp Immunol; 1997 May; 108(2):181-90. PubMed ID: 9158084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of endothelial cell apoptosis by IgG antibodies from SLE patients with nephropathy: a potential role for anti-endothelial cell antibodies.
    van Paassen P; Duijvestijn A; Debrus-Palmans L; Damoiseaux J; Vroomen M; Tervaert JW
    Ann N Y Acad Sci; 2007 Jun; 1108():147-56. PubMed ID: 17893981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load?
    Bengtsson AA; Sturfelt G; Gullstrand B; Truedsson L
    Clin Exp Immunol; 2004 Mar; 135(3):535-43. PubMed ID: 15008990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B.
    Hardin JA; Thomas JO
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7410-4. PubMed ID: 6584863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Suzuki N; Ichino M; Mihara S; Kaneko S; Sakane T
    Arthritis Rheum; 1998 Feb; 41(2):344-53. PubMed ID: 9485093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.